- Home
- GLMD vs TTNP Comparison
GLMD vs TTNP Comparison
Compare GLMD & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- TTNP
- Stock Information
- Founded
- GLMD 2000
- TTNP 1991
- Country
- GLMD Israel
- TTNP United States
- Employees
- GLMD N/A
- TTNP N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLMD Health Care
- TTNP Health Care
- Exchange
- GLMD Nasdaq
- TTNP Nasdaq
- Market Cap
- GLMD 3.0M
- TTNP 3.4M
- IPO Year
- GLMD 2014
- TTNP 1996
- Fundamental
- Price
- GLMD $1.51
- TTNP $4.65
- Analyst Decision
- GLMD Hold
- TTNP
- Analyst Count
- GLMD 1
- TTNP 0
- Target Price
- GLMD N/A
- TTNP N/A
- AVG Volume (30 Days)
- GLMD 255.6K
- TTNP 81.0K
- Earning Date
- GLMD 06-17-2025
- TTNP 05-14-2025
- Dividend Yield
- GLMD N/A
- TTNP N/A
- EPS Growth
- GLMD N/A
- TTNP N/A
- EPS
- GLMD N/A
- TTNP N/A
- Revenue
- GLMD N/A
- TTNP N/A
- Revenue This Year
- GLMD N/A
- TTNP N/A
- Revenue Next Year
- GLMD N/A
- TTNP N/A
- P/E Ratio
- GLMD N/A
- TTNP N/A
- Revenue Growth
- GLMD N/A
- TTNP N/A
- 52 Week Low
- GLMD $1.15
- TTNP $3.03
- 52 Week High
- GLMD $23.80
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- GLMD 56.28
- TTNP 53.37
- Support Level
- GLMD $1.36
- TTNP $4.16
- Resistance Level
- GLMD $1.60
- TTNP $5.12
- Average True Range (ATR)
- GLMD 0.09
- TTNP 0.44
- MACD
- GLMD 0.03
- TTNP -0.01
- Stochastic Oscillator
- GLMD 79.07
- TTNP 51.54
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.